VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Shaanxi Micot Pharmaceutical Submits HKEX Listing Application with Lead Asset MT1013 in Phase III Trials
Shaanxi Micot Pharmaceutical Submits HKEX Listing Application with Lead Asset MT1013 in Phase III Trials
CST Updated Mar 31, 2026 08:34
Share:
